Literature DB >> 2744853

Altered virulence and vaccination properties of Leishmania parasites grown in infected vaccinated mice.

R M Gorczynski1.   

Abstract

BALB/c mice, which are normally highly susceptible to growth of Leishmania mexicana parasites in vivo, can be vaccinated with avirulent temperature-sensitive mutants of L. mexicana so that challenge with virulent organisms results in markedly diminished growth of the latter. Parasites extracted from the lesions which do appear in these mice are able to produce active infection in secondary hosts, although the rate of progression of these lesions is slower than that seen with the original virulent cloned organism. Interestingly, when irradiated parasites from the secondary hosts are themselves used to vaccinate naive BALB/c mice, less protection is seen than when irradiated virulent organisms from the initial infecting clone are used. These data suggest that when infection does take place in mice vaccinated with avirulent clones of parasite, the organisms which develop in lesions in these animals are substantially modified from those present in the initial infecting inoculum.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2744853      PMCID: PMC313465          DOI: 10.1128/iai.57.8.2430-2433.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  T-lymphocytes recognise Leishmania glycoconjugates.

Authors:  G F Mitchell; E Handman
Journal:  Parasitol Today       Date:  1985-08

Review 2.  Functional heterogeneity of CD4+ T cells in leishmaniasis.

Authors:  F Y Liew
Journal:  Immunol Today       Date:  1989-02

3.  Do sugar residues contribute to the antigenic determinants responsible for protection and/or abolition of protection in Leishmania-infected BALB/c mice?

Authors:  R M Gorczynski
Journal:  J Immunol       Date:  1986-08-01       Impact factor: 5.422

4.  Immunization with Leishmania-specific T cell not B cell lines or hybridomas can modulate the response of susceptible mice infected with viable parasites.

Authors:  R M Gorczynski
Journal:  J Immunol       Date:  1987-11-01       Impact factor: 5.422

5.  Identification of an infective stage of Leishmania promastigotes.

Authors:  D L Sacks; P V Perkins
Journal:  Science       Date:  1984-03-30       Impact factor: 47.728

6.  Immunization of susceptible BALB/c mice against Leishmania braziliensis. II. Use of temperature-sensitive avirulent clones of parasite for vaccination purposes.

Authors:  R M Gorczynski
Journal:  Cell Immunol       Date:  1985-08       Impact factor: 4.868

7.  Leishmania tropica major in mice: vaccination against cutaneous leishmaniasis in mice of high genetic susceptibility.

Authors:  G F Mitchell; E Handman
Journal:  Aust J Exp Biol Med Sci       Date:  1983-02

8.  Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes.

Authors:  D L Sacks; S Hieny; A Sher
Journal:  J Immunol       Date:  1985-07       Impact factor: 5.422

9.  Prophylactic immunization against experimental leishmaniasis: I. Protection induced in mice genetically vulnerable to fatal Leishmania tropica infection.

Authors:  J G Howard; S Nicklin; C Hale; F Y Liew
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

10.  Distinctive cellular immunity in genetically susceptible BALB/c mice recovered from Leishmania major infection or after subcutaneous immunization with killed parasites.

Authors:  F Y Liew; J S Dhaliwal
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

View more
  1 in total

1.  Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: a possible hazard for the host.

Authors:  T Aebischer; S F Moody; E Handman
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.